Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Dec;63(6):1622–1630. doi: 10.1086/302161

Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.

M Honsho 1, S Tamura 1, N Shimozawa 1, Y Suzuki 1, N Kondo 1, Y Fujiki 1
PMCID: PMC1377633  PMID: 9837814

Abstract

Peroxisome-biogenesis disorders (PBDs), including Zellweger syndrome (ZS), are autosomal recessive diseases caused by a deficiency in peroxisome assembly as well as by a malfunction of peroxisomes, among which>10 genotypes have been identified. We have isolated a human PEX16 cDNA (HsPEX16) by performing an expressed-sequence-tag homology search on a human DNA database, by using yeast PEX16 from Yarrowia lipolytica and then screening the human liver cDNA library. This cDNA encodes a peroxisomal protein (a peroxin Pex16p) made up of 336 amino acids. Among 13 peroxisome-deficiency complementation groups (CGs), HsPEX16 expression morphologically and biochemically restored peroxisome biogenesis only in fibroblasts from a CG-D patient with ZS in Japan (the same group as CG-IX in the United States). Pex16p was localized to peroxisomes through expression study of epitope-tagged Pex16p. One patient (PBDD-01) possessed a homozygous, inactivating nonsense mutation, C-->T at position 526 in a codon (CGA) for 176Arg, that resulted in a termination codon (TGA). This implies that the C-terminal half is required for the biological function of Pex16p. PBDD-01-derived PEX16 cDNA was defective in peroxisome-restoring activity when expressed in the patient's fibroblasts. These results demonstrate that mutation in PEX16 is the genetic cause of CG-D PBDs.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe I., Okumoto K., Tamura S., Fujiki Y. Clofibrate-inducible, 28-kDa peroxisomal integral membrane protein is encoded by PEX11. FEBS Lett. 1998 Jul 24;431(3):468–472. doi: 10.1016/s0014-5793(98)00815-1. [DOI] [PubMed] [Google Scholar]
  2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J Mol Biol. 1990 Oct 5;215(3):403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  3. Braverman N., Steel G., Obie C., Moser A., Moser H., Gould S. J., Valle D. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet. 1997 Apr;15(4):369–376. doi: 10.1038/ng0497-369. [DOI] [PubMed] [Google Scholar]
  4. Chang C. C., Lee W. H., Moser H., Valle D., Gould S. J. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat Genet. 1997 Apr;15(4):385–388. doi: 10.1038/ng0497-385. [DOI] [PubMed] [Google Scholar]
  5. Distel B., Erdmann R., Gould S. J., Blobel G., Crane D. I., Cregg J. M., Dodt G., Fujiki Y., Goodman J. M., Just W. W. A unified nomenclature for peroxisome biogenesis factors. J Cell Biol. 1996 Oct;135(1):1–3. doi: 10.1083/jcb.135.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dodt G., Braverman N., Wong C., Moser A., Moser H. W., Watkins P., Valle D., Gould S. J. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet. 1995 Feb;9(2):115–125. doi: 10.1038/ng0295-115. [DOI] [PubMed] [Google Scholar]
  7. Eitzen G. A., Szilard R. K., Rachubinski R. A. Enlarged peroxisomes are present in oleic acid-grown Yarrowia lipolytica overexpressing the PEX16 gene encoding an intraperoxisomal peripheral membrane peroxin. J Cell Biol. 1997 Jun 16;137(6):1265–1278. doi: 10.1083/jcb.137.6.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fujiki Y. Molecular defects in genetic diseases of peroxisomes. Biochim Biophys Acta. 1997 Oct 24;1361(3):235–250. doi: 10.1016/s0925-4439(97)00051-3. [DOI] [PubMed] [Google Scholar]
  9. Fukuda S., Shimozawa N., Suzuki Y., Zhang Z., Tomatsu S., Tsukamoto T., Hashiguchi N., Osumi T., Masuno M., Imaizumi K. Human peroxisome assembly factor-2 (PAF-2): a gene responsible for group C peroxisome biogenesis disorder in humans. Am J Hum Genet. 1996 Dec;59(6):1210–1220. [PMC free article] [PubMed] [Google Scholar]
  10. Kinoshita N., Ghaedi K., Shimozawa N., Wanders R. J., Matsuzono Y., Imanaka T., Okumoto K., Suzuki Y., Kondo N., Fujiki Y. Newly identified Chinese hamster ovary cell mutants are defective in biogenesis of peroxisomal membrane vesicles (Peroxisomal ghosts), representing a novel complementation group in mammals. J Biol Chem. 1998 Sep 11;273(37):24122–24130. doi: 10.1074/jbc.273.37.24122. [DOI] [PubMed] [Google Scholar]
  11. Lazarow P. B., Fujiki Y. Biogenesis of peroxisomes. Annu Rev Cell Biol. 1985;1:489–530. doi: 10.1146/annurev.cb.01.110185.002421. [DOI] [PubMed] [Google Scholar]
  12. Moser A. B., Rasmussen M., Naidu S., Watkins P. A., McGuinness M., Hajra A. K., Chen G., Raymond G., Liu A., Gordon D. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr. 1995 Jul;127(1):13–22. doi: 10.1016/s0022-3476(95)70250-4. [DOI] [PubMed] [Google Scholar]
  13. Motley A. M., Hettema E. H., Hogenhout E. M., Brites P., ten Asbroek A. L., Wijburg F. A., Baas F., Heijmans H. S., Tabak H. F., Wanders R. J. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat Genet. 1997 Apr;15(4):377–380. doi: 10.1038/ng0497-377. [DOI] [PubMed] [Google Scholar]
  14. Okumoto K., Bogaki A., Tateishi K., Tsukamoto T., Osumi T., Shimozawa N., Suzuki Y., Orii T., Fujiki Y. Isolation and characterization of peroxisome-deficient Chinese hamster ovary cell mutants representing human complementation group III. Exp Cell Res. 1997 May 25;233(1):11–20. doi: 10.1006/excr.1997.3552. [DOI] [PubMed] [Google Scholar]
  15. Okumoto K., Fujiki Y. PEX12 encodes an integral membrane protein of peroxisomes. Nat Genet. 1997 Nov;17(3):265–266. doi: 10.1038/ng1197-265. [DOI] [PubMed] [Google Scholar]
  16. Okumoto K., Itoh R., Shimozawa N., Suzuki Y., Tamura S., Kondo N., Fujiki Y. Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum Mol Genet. 1998 Sep;7(9):1399–1405. doi: 10.1093/hmg/7.9.1399. [DOI] [PubMed] [Google Scholar]
  17. Okumoto K., Shimozawa N., Kawai A., Tamura S., Tsukamoto T., Osumi T., Moser H., Wanders R. J., Suzuki Y., Kondo N. PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p. Mol Cell Biol. 1998 Jul;18(7):4324–4336. doi: 10.1128/mcb.18.7.4324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Osumi T., Tsukamoto T., Hata S., Yokota S., Miura S., Fujiki Y., Hijikata M., Miyazawa S., Hashimoto T. Amino-terminal presequence of the precursor of peroxisomal 3-ketoacyl-CoA thiolase is a cleavable signal peptide for peroxisomal targeting. Biochem Biophys Res Commun. 1991 Dec 31;181(3):947–954. doi: 10.1016/0006-291x(91)92028-i. [DOI] [PubMed] [Google Scholar]
  19. Otera H., Okumoto K., Tateishi K., Ikoma Y., Matsuda E., Nishimura M., Tsukamoto T., Osumi T., Ohashi K., Higuchi O. Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: studies with PEX5-defective CHO cell mutants. Mol Cell Biol. 1998 Jan;18(1):388–399. doi: 10.1128/mcb.18.1.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Portsteffen H., Beyer A., Becker E., Epplen C., Pawlak A., Kunau W. H., Dodt G. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat Genet. 1997 Dec;17(4):449–452. doi: 10.1038/ng1297-449. [DOI] [PubMed] [Google Scholar]
  21. Poulos A., Christodoulou J., Chow C. W., Goldblatt J., Paton B. C., Orii T., Suzuki Y., Shimozawa N. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J Pediatr. 1995 Oct;127(4):596–599. doi: 10.1016/s0022-3476(95)70121-4. [DOI] [PubMed] [Google Scholar]
  22. Purdue P. E., Zhang J. W., Skoneczny M., Lazarow P. B. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet. 1997 Apr;15(4):381–384. doi: 10.1038/ng0497-381. [DOI] [PubMed] [Google Scholar]
  23. Reuber B. E., Germain-Lee E., Collins C. S., Morrell J. C., Ameritunga R., Moser H. W., Valle D., Gould S. J. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet. 1997 Dec;17(4):445–448. doi: 10.1038/ng1297-445. [DOI] [PubMed] [Google Scholar]
  24. Santos M. J., Hoefler S., Moser A. B., Moser H. W., Lazarow P. B. Peroxisome assembly mutations in humans: structural heterogeneity in Zellweger syndrome. J Cell Physiol. 1992 Apr;151(1):103–112. doi: 10.1002/jcp.1041510115. [DOI] [PubMed] [Google Scholar]
  25. Santos M. J., Imanaka T., Shio H., Small G. M., Lazarow P. B. Peroxisomal membrane ghosts in Zellweger syndrome--aberrant organelle assembly. Science. 1988 Mar 25;239(4847):1536–1538. doi: 10.1126/science.3281254. [DOI] [PubMed] [Google Scholar]
  26. Shimozawa N., Suzuki Y., Zhang Z., Imamura A., Kondo N., Kinoshita N., Fujiki Y., Tsukamoto T., Osumi T., Imanaka T. Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts. Am J Hum Genet. 1998 Dec;63(6):1898–1903. doi: 10.1086/302142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shimozawa N., Suzuki Y., Zhang Z., Imamura A., Tsukamoto T., Osumi T., Tateishi K., Okumoto K., Fujiki Y., Orii T. Peroxisome biogenesis disorders: identification of a new complementation group distinct from peroxisome-deficient CHO mutants and not complemented by human PEX 13. Biochem Biophys Res Commun. 1998 Feb 13;243(2):368–371. doi: 10.1006/bbrc.1997.8067. [DOI] [PubMed] [Google Scholar]
  28. Shimozawa N., Tsukamoto T., Suzuki Y., Orii T., Fujiki Y. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. J Clin Invest. 1992 Nov;90(5):1864–1870. doi: 10.1172/JCI116063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shimozawa N., Tsukamoto T., Suzuki Y., Orii T., Shirayoshi Y., Mori T., Fujiki Y. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science. 1992 Feb 28;255(5048):1132–1134. doi: 10.1126/science.1546315. [DOI] [PubMed] [Google Scholar]
  30. Subramani S. PEX genes on the rise. Nat Genet. 1997 Apr;15(4):331–333. doi: 10.1038/ng0497-331. [DOI] [PubMed] [Google Scholar]
  31. Swinkels B. W., Gould S. J., Bodnar A. G., Rachubinski R. A., Subramani S. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 1991 Nov;10(11):3255–3262. doi: 10.1002/j.1460-2075.1991.tb04889.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tamura S., Okumoto K., Toyama R., Shimozawa N., Tsukamoto T., Suzuki Y., Osumi T., Kondo N., Fujiki Y. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4350–4355. doi: 10.1073/pnas.95.8.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tateishi K., Okumoto K., Shimozawa N., Tsukamoto T., Osumi T., Suzuki Y., Kondo N., Okano I., Fujiki Y. Newly identified Chinese hamster ovary cell mutants defective in peroxisome biogenesis represent two novel complementation groups in mammals. Eur J Cell Biol. 1997 Aug;73(4):352–359. [PubMed] [Google Scholar]
  34. Titorenko V. I., Rachubinski R. A. Mutants of the yeast Yarrowia lipolytica defective in protein exit from the endoplasmic reticulum are also defective in peroxisome biogenesis. Mol Cell Biol. 1998 May;18(5):2789–2803. doi: 10.1128/mcb.18.5.2789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tsukamoto T., Bogaki A., Okumoto K., Tateishi K., Fujiki Y., Shimozawa N., Suzuki Y., Kondo N., Osumi T. Isolation of a new peroxisome-deficient CHO cell mutant defective in peroxisome targeting signal-1 receptor. Biochem Biophys Res Commun. 1997 Jan 13;230(2):402–406. doi: 10.1006/bbrc.1996.5971. [DOI] [PubMed] [Google Scholar]
  36. Tsukamoto T., Miura S., Fujiki Y. Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant. Nature. 1991 Mar 7;350(6313):77–81. doi: 10.1038/350077a0. [DOI] [PubMed] [Google Scholar]
  37. Tsukamoto T., Miura S., Nakai T., Yokota S., Shimozawa N., Suzuki Y., Orii T., Fujiki Y., Sakai F., Bogaki A. Peroxisome assembly factor-2, a putative ATPase cloned by functional complementation on a peroxisome-deficient mammalian cell mutant. Nat Genet. 1995 Dec;11(4):395–401. doi: 10.1038/ng1295-395. [DOI] [PubMed] [Google Scholar]
  38. Tsukamoto T., Shimozawa N., Fujiki Y. Peroxisome assembly factor 1: nonsense mutation in a peroxisome-deficient Chinese hamster ovary cell mutant and deletion analysis. Mol Cell Biol. 1994 Aug;14(8):5458–5465. doi: 10.1128/mcb.14.8.5458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tsukamoto T., Yokota S., Fujiki Y. Isolation and characterization of Chinese hamster ovary cell mutants defective in assembly of peroxisomes. J Cell Biol. 1990 Mar;110(3):651–660. doi: 10.1083/jcb.110.3.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wendland M., Subramani S. Presence of cytoplasmic factors functional in peroxisomal protein import implicates organelle-associated defects in several human peroxisomal disorders. J Clin Invest. 1993 Nov;92(5):2462–2468. doi: 10.1172/JCI116854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wiemer E. A., Brul S., Just W. W., Van Driel R., Brouwer-Kelder E., Van Den Berg M., Weijers P. J., Schutgens R. B., Van Den Bosch H., Schram A. Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts. Eur J Cell Biol. 1989 Dec;50(2):407–417. [PubMed] [Google Scholar]
  42. Wiemer E. A., Nuttley W. M., Bertolaet B. L., Li X., Francke U., Wheelock M. J., Anné U. K., Johnson K. R., Subramani S. Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders. J Cell Biol. 1995 Jul;130(1):51–65. doi: 10.1083/jcb.130.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yahraus T., Braverman N., Dodt G., Kalish J. E., Morrell J. C., Moser H. W., Valle D., Gould S. J. The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J. 1996 Jun 17;15(12):2914–2923. [PMC free article] [PubMed] [Google Scholar]
  44. Yajima S., Suzuki Y., Shimozawa N., Yamaguchi S., Orii T., Fujiki Y., Osumi T., Hashimoto T., Moser H. W. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet. 1992 Mar;88(5):491–499. doi: 10.1007/BF00219334. [DOI] [PubMed] [Google Scholar]
  45. Zoeller R. A., Allen L. A., Santos M. J., Lazarow P. B., Hashimoto T., Tartakoff A. M., Raetz C. R. Chinese hamster ovary cell mutants defective in peroxisome biogenesis. Comparison to Zellweger syndrome. J Biol Chem. 1989 Dec 25;264(36):21872–21878. [PubMed] [Google Scholar]
  46. van den Bosch H., Schutgens R. B., Wanders R. J., Tager J. M. Biochemistry of peroxisomes. Annu Rev Biochem. 1992;61:157–197. doi: 10.1146/annurev.bi.61.070192.001105. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES